Articles tagged "Donors, marginal"

2021 American Transplant Congress
Expanding A₂ to B Kidney Transplantation: Safe and Effective Use of Recipients with High Titer Antibodies
A. Gilbert¹, S. Radomski², J. Verbesey¹, J. Vucci¹, M. Cooper¹
¹Medstar Georgetown Transplant Institute, Washington, DC, ²Department of Surgery, Johns Hopkins Medical Center, Baltimore, MD
*Purpose: Minor ABO incompatible (ABOi) transplants from blood group A2 or A2B donors have increased since 2014, but virtually all centers limit recipients to having…
2021 American Transplant Congress
Trends in the Recovery and Discard of Kidneys from Deceased Donors with Acute Kidney Injury from 2010-2018
C. Liu¹, S. Alasfar², P. P. Reese³, S. Mohan⁴, M. D. Doshi⁵, I. E. Hall⁶, H. R. Thiessen-Philbrook², Y. Jia², D. E. Stewart⁷, C. Parikh²
¹Icahn School of Medicine at Mount Sinai, New York, NY, ²Johns Hopkins University School of Medicine, Baltimore, MD, ³Perelman School of Medicine, Philadelphia, PA, ⁴New York-Presbyterian/Columbia University Irving Medical Center, New York, NY, ⁵University of Michigan, Ann Arbor, MI, ⁶University of Utah School of Medicine, Salt Lake City, UT, ⁷United Network for Organ Sharing, Richmond, VA
*Purpose: Since the donor KDPI score used in KAS is restricted to a single terminal serum creatinine (SCr) measurement, kidneys from donors with transient acute…
2021 American Transplant Congress
Improved Patient Survival in DCD Liver Transplantation
O. Bushara¹, J. Alhalel¹, H. Azad¹, T. Cerri², S. Zafer², J. C. Caicedo¹
¹Department of Surgery, Division of Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL, ²Rosalind Franklin Medical School, Chicago, IL
*Purpose: We aim to investigate longitudinal outcomes in DCD liver transplantation over a 10-year period and elucidate trends in patient survival, biliary complication rates, and…
2021 American Transplant Congress
How Long is the Wait Worthwhile: Cost-Effectiveness of Accepting a Kidney from a Donor with Apolipoprotein L1 High-Risk Genotype
K. Lentine¹, D. Brennan², M. Wang³, M. Schnitzler⁴, H. Xiao⁴, D. Axelrod⁵, J. Snyder⁶, K. Lentine⁴
¹Saint Louis University, St. Louis, MO, ²Johns Hopkins, Baltimore, MD, ³Washington Univ, Saint Louis, MO, ⁴Saint Louis Univ, Saint Louis, MO, ⁵Univ of Iowa, Iowa City, IA, ⁶SRTR, Minneapolis, MN
*Purpose: The Apolipoprotein L1 (APOL1) Long-Term Outcomes (APOLLO) study is underway to define the impact of kidney donor renal risk variants (RRVs) on the survival…
2021 American Transplant Congress
Two-for-One Kidney Transplant Outcomes
C. Malanga¹, H. Madeem², K. Robichaux², J. Buggs³, A. Kumar¹, V. Bowers³
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: In the United States, over 91,000 people are on the waiting list for a kidney transplant. Concurrently, 3,500 kidneys deemed to be of marginal…
2021 American Transplant Congress
Developmental Characteristics and Haemodynamics After Pediatric Donor to Adult Recipients in Liver Transplantation
M. Chen, L. Xiaohong, H. Xitao, C. Zhitao, J. W.
Transplant Center, Sun Yat-sen University, Guangzhou, China
*Purpose: The developmental characteristics and hemodynamics of pediatric liver allografts transplanted into adult recipients remain unclear and deserve exploring.*Methods: Records from adult recipients undergoing liver…
2021 American Transplant Congress
Improved Outcomes Over Time of Extended Criteria Donor Grafts for Acute-on-chronic Liver Failure
T. Kitajima, T. Ivanics, D. Moonka, T. Shamaa, A. Mohamed, K. Delvecchio, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Given the high waitlist mortality of patients with acute-on-chronic liver failure (ACLF), liver transplant (LT) with an extended criteria donor (ECD) can be considered.…
2021 American Transplant Congress
Outcomes in Older Recipients Receiving Kidneys from Donors with Acute Kidney Injury (AKI)
S. Nair, K. Reddy, L. Kodali, P. Budhiraja, J. Ninan, C. Jadlowiec, A. Mathur, J. Harbell, H. Khamash, M. Smith, R. Heilman
Mayo Clinic, Phoenix, AZ
*Purpose: Older patients are perceived to tolerate delayed graft function (DGF) poorly and there is a reluctance to transplant a kidney from an AKI donor…
2021 American Transplant Congress
Pre-Procurement Cardiac Arrest in Lung Allograft Donors and Effects on Recipient Outcomes
T. J. Hathaway, E. C. Klipsch, D. Roe, C. Hage, M. Duncan, R. S. Mangus
Indiana University School of Medicine, Indianapolis, IN
*Purpose: This study seeks to help expand the lung transplant donor pool by demonstrating the safe use of lung allografts from donors who underwent pre-procurement…
2021 American Transplant Congress
Developing and Validation of a Liver Transplantation Donation After Cardiac Death Risk Index Using the UNOS Database
L. Chau, K. Delvecchio, A. Mohamed, M. Lu, T. Kitajima, S. Yedulla, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai
Division of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Donation after cardiac death (DCD) liver transplantation is an increasing form of organ donation. Shlegal et. al. identified seven factors predicting 1-year DCD graft…

« Previous Page
1
…
6
7
8
9
10
…
29
Next Page »